109 related articles for article (PubMed ID: 9532405)
1. Cutaneous T-cell lymphoma: a model for selective immunotherapy.
Edelson RL
Cancer J Sci Am; 1998; 4(2):62-71. PubMed ID: 9532405
[No Abstract] [Full Text] [Related]
2. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
Edelson RL
Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
[TBL] [Abstract][Full Text] [Related]
3. The immunopathogenesis of cutaneous T-cell lymphoma.
Rook AH; Heald P
Hematol Oncol Clin North Am; 1995 Oct; 9(5):997-1010. PubMed ID: 8522492
[TBL] [Abstract][Full Text] [Related]
4. T-cell technology in the diagnosis & management of cutaneous T-cell lymphoma.
Duncan KO; Heald PW
Compr Ther; 1998 Mar; 24(3):117-22. PubMed ID: 9559245
[TBL] [Abstract][Full Text] [Related]
5. [Immuno-intervention in cutaneous lymphomas].
Dummer R; Heinzerling L; Schmid MH; Burg G
Praxis (Bern 1994); 2000 Sep; 89(37):1471-6. PubMed ID: 11037619
[TBL] [Abstract][Full Text] [Related]
6. Immune responses in patients with T-cell lymphoma treated with an anti-idiotype antibody mimicking a highly restricted T-cell antigen.
Foon KA; Oseroff AR; Vaickus L; Greenberg SJ; Russell D; Bernstein Z; Pincus S; Köhler H; Seon BK; Tahaoglu E
Clin Cancer Res; 1995 Nov; 1(11):1285-94. PubMed ID: 9815923
[TBL] [Abstract][Full Text] [Related]
7. Advances in understanding the immunobiology and immunotherapy of cutaneous T-cell lymphoma.
Berger CL; Mariwalla K; Girardi M; Edelson RL
Adv Dermatol; 2004; 20():217-35. PubMed ID: 15544202
[No Abstract] [Full Text] [Related]
8. Skin-homing CD8+ T lymphocytes show preferential growth in vitro and suppress CD4+ T-cell proliferation in patients with early stages of cutaneous T-cell lymphoma.
Thestrup-Pedersen K; Parhar R; Wu K; Bertilsson PA; Meyer B; Abu-Amero S; Hainau B; Aleisa A; Alfadley A; Hamadah I; Alajlan A; Al-Hussein K; Al-Mohanna F
Acta Derm Venereol; 2007; 87(2):118-26. PubMed ID: 17340017
[TBL] [Abstract][Full Text] [Related]
9. [Management of cutaneous lymphoma ].
Beylot-Barry M; Battistella M
Ann Dermatol Venereol; 2011 May; 138(5 Suppl 2):H13-8. PubMed ID: 21703465
[No Abstract] [Full Text] [Related]
10. Subcutaneous panniculitis-like T-cell lymphoma: a clinicopathologic, immunophenotypic, and molecular study of 22 Asian cases according to WHO-EORTC classification.
Kong YY; Dai B; Kong JC; Zhou XY; Lu HF; Shen L; Du X; Shi DR
Am J Surg Pathol; 2008 Oct; 32(10):1495-502. PubMed ID: 18708940
[TBL] [Abstract][Full Text] [Related]
11. Immunomodulatory therapy of cutaneous T-cell lymphoma: a multimodality approach in advanced disease.
Junkins-Hopkins JM
J Am Acad Dermatol; 2009 Dec; 61(6):1056-8. PubMed ID: 19925930
[TBL] [Abstract][Full Text] [Related]
12. Graft-versus-lymphoma effect.
Richard C; Bermúdez A; Izu R
Br J Haematol; 2010 Apr; 149(2):166. PubMed ID: 20015300
[No Abstract] [Full Text] [Related]
13. Photopheresis: present and future aspects.
Edelson RL
J Photochem Photobiol B; 1991 Jul; 10(1-2):165-71. PubMed ID: 1955944
[No Abstract] [Full Text] [Related]
14. Diffuse large cell non-Hodgkin's lymphoma, CD30+, T-cell phenotype.
Gruson LM; Latkowski JA
Dermatol Online J; 2005 Dec; 11(4):17. PubMed ID: 16403389
[TBL] [Abstract][Full Text] [Related]
15. Anti-tumor immune responses and tumor regression induced with mimotopes of a tumor-associated T cell epitope.
Tumenjargal S; Gellrich S; Linnemann T; Muche JM; Lukowsky A; Audring H; Wiesmüller KH; Sterry W; Walden P
Eur J Immunol; 2003 Nov; 33(11):3175-85. PubMed ID: 14579286
[TBL] [Abstract][Full Text] [Related]
16. [Contribution of immunotherapy to the treatment of T-cell lymphoma of the skin].
Bagot M; Boumsell L; Bensussan A
Presse Med; 1999 Nov; 28(34):1911-6. PubMed ID: 10587730
[TBL] [Abstract][Full Text] [Related]
17. [Cutaneous lymphoma of the Sézary and Bouvrain type. Progress in physiopathologic and therapeutic outlook].
Bagot M
Bull Acad Natl Med; 1998; 182(5):927-37; discussion 937-8. PubMed ID: 9735499
[TBL] [Abstract][Full Text] [Related]
18. CD4/CD8 double-positive, acute type of adult T-cell leukemia/lymphoma with extensive cutaneous involvement.
Kim YJ; Hwang ES; Kim IH; Yu DS
Int J Dermatol; 2006 Oct; 45(10):1193-5. PubMed ID: 17040438
[No Abstract] [Full Text] [Related]
19. Cytotoxic/natural killer cell cutaneous lymphomas. Report of EORTC Cutaneous Lymphoma Task Force Workshop.
Santucci M; Pimpinelli N; Massi D; Kadin ME; Meijer CJ; Müller-Hermelink HK; Paulli M; Wechsler J; Willemze R; Audring H; Bernengo MG; Cerroni L; Chimenti S; Chott A; Díaz-Pérez JL; Dippel E; Duncan LM; Feller AC; Geerts ML; Hallermann C; Kempf W; Russell-Jones R; Sander C; Berti E;
Cancer; 2003 Feb; 97(3):610-27. PubMed ID: 12548603
[TBL] [Abstract][Full Text] [Related]
20. Monitoring the decrease of circulating malignant T cells in cutaneous T-cell lymphoma during photopheresis and interferon therapy.
Ferenczi K; Yawalkar N; Jones D; Kupper TS
Arch Dermatol; 2003 Jul; 139(7):909-13. PubMed ID: 12873887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
